Millions in funding and new board members for Belgian mRNA company
The mRNA technologies company eTheRNA has raised €39 million ($38.7 million) in series B2 financing.…
August 24, 2022 - 3 minutes
The mRNA technologies company eTheRNA has raised €39 million ($38.7 million) in series B2 financing.…